Nuvalent 8-K Signals Update on Financial Condition

TL;DR

**Nuvalent just dropped an 8-K on financial results, watch for details!**

AI Summary

Nuvalent, Inc. filed an 8-K on January 9, 2024, reporting an event that occurred on January 8, 2024, related to 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'. This filing indicates that Nuvalent, Inc. is providing an update on its financial performance or condition, which could include preliminary earnings, a change in financial outlook, or other material financial information. For investors, this matters because it provides timely insight into the company's financial health and operational results, which can directly influence stock valuation and future investment decisions.

Why It Matters

This filing signals that Nuvalent, Inc. is disclosing important financial information, which could impact its stock price and investor sentiment. Investors need to review the full details to understand the implications for the company's future performance.

Risk Assessment

Risk Level: medium — The risk is medium because an 8-K on financial condition can contain either positive or negative news, creating uncertainty until the full details are disclosed.

Analyst Insight

A smart investor would immediately look for the full content of the 8-K filing to understand the specific details of the 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' to assess the impact on Nuvalent, Inc.'s valuation.

Key Players & Entities

• Nuvalent, Inc. (company) — the registrant filing the 8-K
• January 8, 2024 (date) — date of the earliest event reported
• January 9, 2024 (date) — date the 8-K was filed
• 001-40671 (other) — Commission File Number
• NUVL (other) — Trade Symbol for Class A Common Stock

FAQ

Key Financial Figures

• $0.0001 — hich registered Class A Common Stock, $0.0001 par value per share NUVL The Nasdaq
• $719.9 million — December 31, 2023, it had approximately $719.9 million in cash, cash equivalents and marketabl

Filing Documents

• nuvl-20240108.htm (8-K) — 48KB
• nuvl-ex99_1.htm (EX-99.1) — 36KB
• img8926856_0.jpg (GRAPHIC) — 8KB
• 0000950170-24-003376.txt ( ) — 222KB
• nuvl-20240108.xsd (EX-101.SCH) — 30KB
• nuvl-20240108_htm.xml (XML) — 5KB

02

Item 2.02 Results of Operations and Financial Condition. On January 8, 2024, Nuvalent, Inc. (the “Company”) issued a press release in which it reported a preliminary estimate that, as of December 31, 2023, it had approximately $719.9 million in cash, cash equivalents and marketable securities. This amount is a preliminary, unaudited estimate only as of January 8, 2024, is subject to completion of the Company’s year-end financial closing procedures that could result in changes to the amount, and does not present all information necessary for an understanding of the Company’s financial condition as of December 31, 2023. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Forward-Looking Statements

Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, implied and express statements regarding the Company’s estimate of its cash, cash equivalents and marketable securities as of December 31, 2023. Any forward-looking statements in this Current Report on Form 8-K are based on management’s current expectations and beliefs and are subject to a number of risks, uncertainties, and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this Current Report on Form 8-K, including the risks and uncertainties described in greater detail in the section entitled “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2023, as well as any prior and subsequent filings with the Securities and Exchange Commission. In addition, any forward-looking statements represent the Company’s views only as of the date of this Current Report on Form 8-K and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits The following exhibit relating to Item 2.02 of this Form 8-K shall be deemed to be furnished and not filed: Exhibit No. Description 99.1 Press Release issued by Nuvalent, Inc. on January 8, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Nuvalent, Inc. Date: January 9, 2024 By: /s/ Deborah A. Miller Deborah A. Miller, Ph.D. Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR